Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytochrome P450 enzymes: Central players in cardiovascular health and disease
Reem H. Elbekai, Ayman O.S. El‐Kadi
Pharmacology & Therapeutics (2006) Vol. 112, Iss. 2, pp. 564-587
Closed Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues
Ivan Bièche, Céline Narjoz, Tarik Asselah, et al.
Pharmacogenetics and Genomics (2007) Vol. 17, Iss. 9, pp. 731-742
Closed Access | Times Cited: 338
Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Natalie C. Sondermann, Sonja Faßbender, Frederick Hartung, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115371-115371
Open Access | Times Cited: 71
Cytochrome P450-mediated metabolism in the human gut wall
Jennifer B. Dressman, Kirstin Thelen
Journal of Pharmacy and Pharmacology (2009) Vol. 61, Iss. 5, pp. 541-558
Closed Access | Times Cited: 254
Cytochrome P450-mediated metabolism in the human gut wall
Kirstin Thelen, Jennifer B. Dressman
Journal of Pharmacy and Pharmacology (2009) Vol. 61, Iss. 5, pp. 541-558
Open Access | Times Cited: 229
Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases
Beshay N. Zordoky, Ayman O.S. El‐Kadi
Pharmacology & Therapeutics (2010) Vol. 125, Iss. 3, pp. 446-463
Closed Access | Times Cited: 171
Potential role of CYP1B1 in the development and treatment of metabolic diseases
Fei Li, Weifeng Zhu, Frank J. Gonzalez
Pharmacology & Therapeutics (2017) Vol. 178, pp. 18-30
Open Access | Times Cited: 167
Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular Tissues
Tracy C. DeLozier, Grace E. Kissling, Sherry J. Coulter, et al.
Drug Metabolism and Disposition (2007) Vol. 35, Iss. 4, pp. 682-688
Open Access | Times Cited: 162
Exposure to acrylamide and the risk of cardiovascular diseases in the National Health and Nutrition Examination Survey 2003–2006
Yu Zhang, Mengmeng Huang, Pan Zhuang, et al.
Environment International (2018) Vol. 117, pp. 154-163
Closed Access | Times Cited: 91
Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats
Beshay N. Zordoky, Mona E. Aboutabl, Ayman O.S. El‐Kadi
Drug Metabolism and Disposition (2008) Vol. 36, Iss. 11, pp. 2277-2286
Closed Access | Times Cited: 120
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model
Jun‐Yan Liu, Jun Yang, Bora İnceoğlu, et al.
Biochemical Pharmacology (2009) Vol. 79, Iss. 6, pp. 880-887
Open Access | Times Cited: 119
Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health
Rafat A. Siddiqui, Kevin Harvey, Gary P. Zaloga
The Journal of Nutritional Biochemistry (2007) Vol. 19, Iss. 7, pp. 417-437
Closed Access | Times Cited: 115
H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart
Beshay N. Zordoky, Ayman O.S. El‐Kadi
Journal of Pharmacological and Toxicological Methods (2007) Vol. 56, Iss. 3, pp. 317-322
Closed Access | Times Cited: 115
Different Patterns of Oxidized Lipid Products in Plasma and Urine of Dengue Fever, Stroke, and Parkinson's Disease Patients: Cautions in the Use of Biomarkers of Oxidative Stress
Jetty Chung‐Yung Lee, Raymond C.S. Seet, Shan Huang, et al.
Antioxidants and Redox Signaling (2008) Vol. 11, Iss. 3, pp. 407-420
Open Access | Times Cited: 101
Rationally Designed Multitarget Agents Against Inflammation and Pain
Sung Hee Hwang, Aaron T. Wecksler, Karen Wagner, et al.
Current Medicinal Chemistry (2013) Vol. 20, Iss. 13, pp. 1783-1799
Open Access | Times Cited: 98
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
Jun‐Yan Liu, Hsing‐Ju Tsai, Sung Hee Hwang, et al.
British Journal of Pharmacology (2009) Vol. 156, Iss. 2, pp. 284-296
Open Access | Times Cited: 97
Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell Growth
Chen Chen, Xin Wei, Xiaoquan Rao, et al.
Journal of Pharmacology and Experimental Therapeutics (2010) Vol. 336, Iss. 2, pp. 344-355
Open Access | Times Cited: 96
Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity
Yunfang Zhang, Haitham El‐Sikhry, Ketul R. Chaudhary, et al.
AJP Heart and Circulatory Physiology (2009) Vol. 297, Iss. 1, pp. H37-H46
Open Access | Times Cited: 92
Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders
Payman Shahabi, Gérard Siest, Urs Meyer, et al.
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 2, pp. 134-161
Closed Access | Times Cited: 87
Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance
Meijuan Xu, Wen-zheng Ju, Haiping Hao, et al.
Drug Metabolism Reviews (2013) Vol. 45, Iss. 3, pp. 311-352
Closed Access | Times Cited: 84
Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation
Carmine Rocca, Teresa Pasqua, Maria Carmela Cerra, et al.
Antioxidants and Redox Signaling (2020) Vol. 32, Iss. 15, pp. 1081-1097
Closed Access | Times Cited: 52
Sexual Dimorphism in the Expression of Cytochrome P450 Enzymes in Rat Heart, Liver, Kidney, Lung, Brain, and Small Intestine
Samar H. Gerges, Ayman O.S. El‐Kadi
Drug Metabolism and Disposition (2022) Vol. 51, Iss. 1, pp. 81-94
Open Access | Times Cited: 30
Fatty acids act on vascular endothelial cells and influence the development of cardiovascular disease
Kazuo Yamagata
Prostaglandins & Other Lipid Mediators (2023) Vol. 165, pp. 106704-106704
Closed Access | Times Cited: 20
Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease
Linna Xu, Qingqing Yang, Jinghua Zhou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8465-8465
Open Access | Times Cited: 6
Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease
Pietro Minuz, Houli Jiang, Cristiano Fava, et al.
Hypertension (2008) Vol. 51, Iss. 5, pp. 1379-1385
Open Access | Times Cited: 95
Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples
Yasukazu Yoshida, Shintaro Kodai, Shigekazu Takemura, et al.
Analytical Biochemistry (2008) Vol. 379, Iss. 1, pp. 105-115
Closed Access | Times Cited: 88
Page 1 - Next Page

Scroll to top